Optimizing clinical trial site performance: A focus on three AI capabilities
IBM Business Partners
AUGUST 7, 2023
Despite advancements in the pharmaceutical industry and biomedical research, delivering drugs to market is still a complex process with tremendous opportunity for improvement. Additionally, biopharma companies may find themselves building out AI capabilities in-house sporadically and without overarching governance.
Let's personalize your content